Event: ECTRIMS 2022

0:01:53

The ECTRIMS 2022 Event for People with MS

0:11:19

Flipping the pyramid and beyond ECTRIMS 2022

0:02:40

ECTRIMS 2022 Highlights

1:58:02

ECTRIMS 2022: For People Living with MS (in Dutch)

1:58:08

ECTRIMS 2022: For People with MS (in English)

0:07:37

Key updates and research focuses at ECTRIMS 2022

0:03:45

Exciting ECTRIMS 2022 Announcement

1:58:06

ECTRIMS 2022: For People with MS (in French)

1:58:05

ECTRIMS 2022: For People with MS (in Italian)

1:58:03

ECTRIMS 2022: For People with MS (in Spanish)

0:00:47

ECTRIMS 2022: Experience the Evolution

0:16:01

ECTRIMS 2022: Research Insights from Day One

1:58:03

ECTRIMS 2022: For People with MS (in German)

0:01:42

Groundbreaking News From ECTRIMS 2022

0:04:03

What Are 'High Efficacy Therapies' For MS? w/Dr Dalia Rotstein | ECTRIMS 2022

1:21:52

MStranslate & ECTRIMS 2022: Multiple Sclerosis Research Update with Brett Drummond

0:24:39

ECTRIMS 2022 Press Conference

0:05:04

Barry Singer, ECTRIMS 2022: Diroximel fumarate for RRMS – Phase 3 results from EVOLVE-MS-1

0:14:46

Do THIS to Get Your Doctor to Understand You | Chat w/ Dr Aaron Boster at ECTRIMS 2022

0:17:22

ECTRIMS 2022: Research Insights from Day Three

0:15:01

ECTRIMS 2022: Research Insights from Day Two

0:03:08

ECTRIMS Focused Workshop 2021 - Highlights

0:06:43

Sean Pittock, ECTRIMS 2022: Phase 3 CHAMPION-NMOSD trial results – Ravulizumab for AQP4-IgG NMOSD

0:56:57

MS Hangout ECTRIMS 2022 Amsterdam